Cargando…
Aggressive Natural Killer Cell Leukemia: A Brief Overview of Its Genomic Landscape, Histological Features, and Current Management
Aggressive natural killer-cell leukemia (ANKL) is a rare hematological malignancy characterized by the abnormal proliferation of natural killer (NK) cells. There are currently no therapies approved by the US Food and Drug Administration (FDA) for the treatment of ANKL, but advancements in genomics a...
Autores principales: | Sumbly, Vikram, Vest, Mallorie, Landry, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956279/ https://www.ncbi.nlm.nih.gov/pubmed/35345687 http://dx.doi.org/10.7759/cureus.22537 |
Ejemplares similares
-
Advancements in the Treatment of Triple-Negative Breast Cancer: A Narrative Review of the Literature
por: Landry, Ian, et al.
Publicado: (2022) -
Clostridium difficile Infection Complicated by Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia With Leukostasis and Sweet’s Syndrome
por: Landry, Ian, et al.
Publicado: (2021) -
Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
por: Sumbly, Vikram, et al.
Publicado: (2022) -
Biliary Anastomosis Using T-tube Versus No T-tube for Liver Transplantation in Adults: A Review of Literature
por: Vest, Mallorie, et al.
Publicado: (2022) -
Facial Genetics: A Brief Overview
por: Richmond, Stephen, et al.
Publicado: (2018)